Are you saying $300/share? That would put us at a $450 billion market cap making us the second largest pharmaceutical company behind Eli Lily and worth a full $100 billion more than Johnson and Johnson. I'm not saying it's impossible but that doesn't seem very likely and if we did ever achieve that it would be a long time from today.

12 years ago, that may have been more realistic when we had way less shares outstanding, but management would have to buy back a lot of shares to get us up to $300/share imo.